BR112018013902A2 - métodos para melhorar saúde das articulações, para aumentar força e massa muscular. - Google Patents

métodos para melhorar saúde das articulações, para aumentar força e massa muscular.

Info

Publication number
BR112018013902A2
BR112018013902A2 BR112018013902A BR112018013902A BR112018013902A2 BR 112018013902 A2 BR112018013902 A2 BR 112018013902A2 BR 112018013902 A BR112018013902 A BR 112018013902A BR 112018013902 A BR112018013902 A BR 112018013902A BR 112018013902 A2 BR112018013902 A2 BR 112018013902A2
Authority
BR
Brazil
Prior art keywords
joint
improve
hmb
methods
muscle mass
Prior art date
Application number
BR112018013902A
Other languages
English (en)
Inventor
Harris Emily
Fuller John
Rathmacher John
Baier Shawn
Original Assignee
Metabolic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolic Tech Inc filed Critical Metabolic Tech Inc
Publication of BR112018013902A2 publication Critical patent/BR112018013902A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

a presente invenção provê uma composição compreendendo hmb. métodos para administrar hmb a um animal são também descritos. hmb é administrado para diminuir instabilidade das articulações, aumentar estabilidade das articulações, diminuir rigidez das articulações, melhorar funcionamento das articulações, melhorar saúde das articulações, melhorar movimento equilibrado e melhorar estabilidade das articulações do esqueleto durante movimento muscular. hmb é administrado para aumentar força muscular e/ou massa muscular em um lado do corpo contralateral a inflamação nas articulações, dano nas articulações e/ou ferimento nas articulações.
BR112018013902A 2016-01-13 2017-01-13 métodos para melhorar saúde das articulações, para aumentar força e massa muscular. BR112018013902A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662278252P 2016-01-13 2016-01-13
PCT/US2017/013404 WO2017123922A1 (en) 2016-01-13 2017-01-13 COMPOSITIONS AND METHODS OF USE OF β-HYDROXY-β-METHYLBUTYRATE (HMB) FOR JOINT STABILITY

Publications (1)

Publication Number Publication Date
BR112018013902A2 true BR112018013902A2 (pt) 2018-12-18

Family

ID=59274715

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018013902A BR112018013902A2 (pt) 2016-01-13 2017-01-13 métodos para melhorar saúde das articulações, para aumentar força e massa muscular.

Country Status (9)

Country Link
US (1) US20170196824A1 (pt)
EP (1) EP3402476A4 (pt)
JP (2) JP7401969B2 (pt)
CN (2) CN108697675A (pt)
AU (1) AU2017207910B2 (pt)
BR (1) BR112018013902A2 (pt)
CA (1) CA3011364A1 (pt)
MX (1) MX2018008589A (pt)
WO (1) WO2017123922A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024153236A1 (zh) * 2023-01-19 2024-07-25 南京纽邦生物科技有限公司 3-羟基-3-甲基丁酸与其盐的复合物以及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050215640A1 (en) * 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
EP1973426A2 (en) * 2005-11-03 2008-10-01 Southwest Immunology Inc. Compositions for preventing and reducing delayed onset muscle soreness
US9259430B2 (en) * 2008-12-09 2016-02-16 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
ES2608483T3 (es) * 2009-12-18 2017-04-11 Metabolic Technologies, Inc. Método mejorado de administración de beta-hidroxi-beta-metilbutirato (HMB)
WO2013170189A1 (en) * 2012-05-11 2013-11-14 Abbott Laboratories Combination of beta - hydroxy - beta - methylbutyrate and beta - alanine for increasing muscle blood flow
WO2014099904A1 (en) * 2012-12-17 2014-06-26 Abbott Laboratories Methods for enhancing motor function, enhancing functional status and mitigating muscle weakness in a subject
CA2903565A1 (en) * 2013-03-15 2014-09-18 Abbott Laboratories Methods of maintaining and improving muscle function using epigallocatechin-3-gallate
SG11201508388YA (en) * 2013-05-01 2015-11-27 Abbott Lab Methods for enhancing aged muscle regeneration
JP6123520B2 (ja) * 2013-07-01 2017-05-10 富士通株式会社 下肢形状変化測定装置、方法及びプログラム
US20150057346A1 (en) * 2013-08-23 2015-02-26 Abbott Laboratories Methods of maintaining intramuscular myoglobin levels, maintaining maximal aerobic capacity, and enhancing the oxidative capacity of muscle in a subject
US20150057350A1 (en) * 2013-08-23 2015-02-26 Abbott Laboratories Fibrosis biomarkers and methods of using same
US20160361291A1 (en) * 2013-12-18 2016-12-15 Abbott Laboratories Methods for increasing skeletal muscle protein synthesis using green tea extract
JP2015134074A (ja) * 2014-01-17 2015-07-27 株式会社タニタ 生体測定装置
JPWO2015137387A1 (ja) * 2014-03-11 2017-04-06 協和発酵バイオ株式会社 筋肉増強剤

Also Published As

Publication number Publication date
JP2022001586A (ja) 2022-01-06
MX2018008589A (es) 2018-11-09
CA3011364A1 (en) 2017-07-20
EP3402476A4 (en) 2019-09-18
AU2017207910B2 (en) 2022-09-01
CN108697675A (zh) 2018-10-23
WO2017123922A1 (en) 2017-07-20
AU2017207910A1 (en) 2018-07-19
JP7401969B2 (ja) 2023-12-20
JP2019507727A (ja) 2019-03-22
US20170196824A1 (en) 2017-07-13
EP3402476A1 (en) 2018-11-21
CN116999422A (zh) 2023-11-07

Similar Documents

Publication Publication Date Title
BR112017014088A2 (pt) aparelho dentário que fornece superfícies oclusais expostas
CY1124135T1 (el) Δοσολογικα σχηματα για την αγωγη της νοσου ρομρε
MX2022011334A (es) Tratamiento de la enfermedad de fabry en pacientes no tratados y tratados previamente con ert.
BR112015026122A2 (pt) métodos para usar interleucina-10 para tratar doenças e desordens
BR112013010556A2 (pt) métodos e composições adequadas para a promoção de uma pele saudável
PH12020500543A1 (en) Nonracemic mixtures and uses thereof
BR112017019829A2 (pt) antagonista do receptor nk-3, para o tratamento terapêutico ou cosmético de gordura corporal em excesso
EA201691656A2 (ru) Терапевтические способы с применением норибогаина и родственных соединений
MX2023005628A (es) Metodos para aumentar y/o estabilizar la funcion cardiaca en pacientes con enfermedad de fabry.
MX2017015418A (es) Composiciones y metodos de uso de beta-hidroxi-beta-metilbutirato (hmb) para reducir grasa corporal.
MX2017002948A (es) Métodos de tratamiento para la sarcoidosis pulmonar.
MX2018008903A (es) COMPOSICIONES Y METODOS DE USO DE ß-HIDROXI-ß-METILBUTIRATO (HMB) PARA MODULAR AUTOFAGIA Y LIPOFAGIA.
BR112015017903A2 (pt) vacina de subunidade de mycobacterium avium subsp. paratuberculosis única ou de múltiplos estágios
MX2016013611A (es) Uso del compuesto antigeno 4 del linfocito t toxico (ctla4) para lograr la remision libre de farmacos en sujetos con artritis reumatoide (ra) temprana.
BR112018013902A2 (pt) métodos para melhorar saúde das articulações, para aumentar força e massa muscular.
EA201791895A1 (ru) Дозы и способы введения телаванцина
BR112018002075A2 (pt) ?artigo absorvente do tipo calça?
BR112015026973A2 (pt) uso de vanoxerina no tratamento de arritmia cardíaca
CO2019007188A2 (es) Secuelas de lesión pulmonar inducida por baipás cardiopulmonar
BR112017016278A2 (pt) agente preventivo e/ou terapêutico de doença imune
EA201000672A1 (ru) Комбинезон для нейроортопедической реабилитации
EA201590982A1 (ru) Новые соединения в качестве ингибиторов диацилглицерин ацилтрансферазы
MY174186A (en) Use of an isopropanol-containing solution to combat caliciviridae
UA102567U (uk) Спосіб корекції імунної системи телят за умов антибіотикотерапії, при лікуванні респіраторних захворювань запального характеру
IT201700070978A1 (it) Apparecchiatura per il trattamento terapeutico del corpo umano

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]